News

Clinical Lab Products
clpmag. com > diagnostic-technologies > digital-pathology > ai-pathology-tool-predicts-immunotherapy-response-rare-cancers

AI Pathology Tool Predicts Immunotherapy Success in Rare Cancers

5+ hour, 18+ min ago  (335+ words) Jul 7, 2026 | Anatomic Pathology, Digital Pathology | Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that an artificial intelligence (AI)-based analysis of tumor biopsies can predict responses to immunotherapy in patients with rare cancers, according to a…...

Symbols: path-io
Clinical Lab Products
clpmag. com > disease-states > cancer > colorectal > blood-test-ctdna-guides-chemotherapy-colorectal-cancer-liver-metastases

Blood Test May Identify Colorectal Cancer Patients Who Benefit from Chemotherapy

22+ hour, 2+ min ago  (458+ words) Jul 6, 2026 | Colorectal | A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented at the European Society for Medical Oncology (ESMO)…...

Clinical Lab Products
clpmag. com > diagnostic-technologies > hematology-serology > hematology-instrumentation > algocyte-launches-portable-ai-blood-analyzer-ukca-cleared

Algocyte Unveils Portable AI Blood Analyzer for Remote Monitoring

1+ day, 5+ hour ago  (298+ words) Jul 6, 2026 | Hematology Instrumentation | Algocyte unveiled its Algocyte Proxima Mobile Health Station, a portable hematology instrument designed for regular and remote blood monitoring. The device, a complete blood count analyzer, was designed and manufactured in the United Kingdom. The system is…...

Symbols: btc-usd
Clinical Lab Products
clpmag. com > disease-states > dementias-alzheimer > nih-blood-test-circular-rna-alzheimers-prediction

Blood Circular RNAs Outperform p Tau217 in Predicting Alzheimer's Disease Progression

1+ day, 5+ hour ago  (369+ words) Jul 6, 2026 | Dementias & Alzheimer's | Elevated levels of specific circular RNAs in the blood nearly tripled the risk of developing Alzheimer's disease symptoms, according to a study funded by the National Institutes of Health (NIH). The research suggests these molecules are more…...

Symbols: d05.S0,u11.S0,z74.S0,a31.S0,six:ro
Google News
clpmag. com > disease-states > cancer > caris-detect-multi-cancer-blood-test-launch

Caris Life Sciences Launches Caris Detect Blood Test for Early Cancer Detection

1+ day, 5+ hour ago  (224+ words) Jul 6, 2026 | Cancer, Company News, Molecular Diagnostics | Caris Life Sciences announced the commercial launch of Caris Detect, a multi-cancer early detection blood test designed to identify cancer signals at earlier stages. The test uses ultra-deep whole genome sequencing, whole transcriptome sequencing,…...

Symbols: nasdaq:cai
Clinical Lab Products
clpmag. com > disease-states > infectious-diseases > colombia-approves-crispr-tb-blood-test

Colombia Approves CRISPR-Based Blood Test for Tuberculosis

5+ day, 3+ hour ago  (201+ words) Jul 2, 2026 | Infectious Diseases | Colombia's National Institute for Food and Drug Surveillance (INVIMA) has granted sanitary registration for the CRISPR-TB Blood Test Kit, allowing for the commercialization of the molecular diagnostic throughout the country. The registration, issued under INVIMA Registration No....

Symbols: mdr-tb
Clinical Lab Products
clpmag. com > disease-states > dementias-alzheimer > alzheimers-biomarkers-predict-cognitive-decline-elderly-patients

Study Supports Prognostic Value of Alzheimer's Biomarkers in Adults Over 80 With Mild Cognitive Impairment

5+ day, 3+ hour ago  (443+ words) Jul 2, 2026 | Dementias & Alzheimer's | Researchers at the Sant Pau Research Institute found that Alzheimer's disease biomarkers can predict rapid cognitive decline in individuals aged 80 and older. The study, published in Neurology, suggests that identifying underlying pathology provides relevant clinical information even…...

Symbols: cdr-sb,mmp-10,habs-hd
Clinical Lab Products
clpmag. com > lab-management > company-news > unitedhealth-covers-shield-blood-test-colorectal-cancer-screening

United Health Group Covers Shield Blood Test for Colorectal Cancer Screening

5+ day, 4+ hour ago  (212+ words) Jul 2, 2026 | Colorectal, Company News | Guardant Health announced that its Shield blood test for colorectal cancer screening is now covered for eligible United Health Group members aged 45 or older. Approximately 40 million people are covered by United Health Group plans, including members…...

Symbols: nyse:abt,nasdaq:gh,tse:mfc,nyse:mfc
Clinical Lab Products
clpmag. com > disease-states > cancer > melanoma > i31-slnb-test-improves-melanoma-lymph-node-risk-assessment

Test Outperforms Traditional Tool in Predicting Melanoma Spread to Lymph Nodes

5+ day, 3+ hour ago  (142+ words) Clinical Lab Products Jul 2, 2026 | Melanoma | Castle Biosciences announced the publication of a prospective, multicenter study showing that its Decision Dx-Melanoma integrated sentinel lymph node biopsy (i31-SLNB) test result more accurately identifies patients at risk of sentinel lymph node positivity than…...

Symbols: nasdaq:cstl
Clinical Lab Products
clpmag. com > lab-essentials > quality-systems > standards > adlm-guidance-lab-testing-gender-diverse-patients

ADLM Issues Guidance on Laboratory Testing for Gender-Diverse Patients

5+ day, 4+ hour ago  (207+ words) Jul 2, 2026 | Standards | The Association for Diagnostics & Laboratory Medicine (ADLM) has released US guidance to help laboratory medicine professionals navigate challenges when caring for gender-diverse patients. As gender-affirming care becomes more common, laboratory professionals face questions about how to accurately interpret…...

Symbols: host-tt